β2-adrenergic receptor-mediated negative regulation of group 2 innate lymphoid cell responses

Science

Volumn 359, Issue 6379, 2018, Pages 1056-1061

  Moriyama, Saya ^a   Brestoff, Jonathan R ^a,b   Flamar, Anne Laure ^a   Moeller, Jesper B ^a,c   Klose, Christoph S N ^a   Rankin, Lucille C ^a   Yudanin, Naomi A ^a   Monticelli, Laurel A ^a   Putzel, Gregory Garbès ^a   Rodewald, Hans Reimer ^d   Artis, David ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; CLENBUTEROL; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;

ANATOMY; CELL; INFECTIOUS DISEASE; INHIBITION; MOLECULAR ANALYSIS; PROTEIN;

ADRENERGIC NERVE CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME INHIBITION; ENZYME REGULATION; GROUP 2 INNATE LYMPHOID CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; INFLAMMATION; INTESTINE; LUNG; LYMPHOID CELL; MOUSE; NIPPOSTRONGYLUS BRASILIENSIS; NIPPOSTRONGYLUS BRASILIENSIS INFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TRICHOSTRONGYLOIDIASIS; ADAPTIVE IMMUNITY; ANIMAL; C57BL MOUSE; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; LYMPHOCYTE; METABOLISM; NERVE CELL NETWORK;

MURINAE;

ADAPTIVE IMMUNITY; ADRENERGIC BETA-2 RECEPTOR AGONISTS; ADRENERGIC NEURONS; ANIMALS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INTESTINES; LUNG; LYMPHOCYTES; MICE; MICE, INBRED C57BL; NERVE NET; RECEPTORS, ADRENERGIC, BETA-2; SIGNAL TRANSDUCTION;

EID: 85042871831     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.aan4829     Document Type: Article

References (28)

1. B. Pulendran, D. Artis, Science 337, 431-435 (2012).
2. H. Hammad, B. N. Lambrecht, Immunity 43, 29-40 (2015).
3. R. M. Locksley, Cell 140, 777-783 (2010).
4. R. M. Anthony, L. I. Rutitzky, J. F. Urban Jr., M. J. Stadecker, W. C. Gause, Nat Rev. Immunol. 7, 975-987 (2007).
5. D. Artis, H. Spits, Nature 517, 293-301 (2015).
6. A. B. Molofsky, A. K. Savage, R. M. Locksley, Immunity 42, 1005-1019 (2015).
7. G. Eberl, M. Colonna, J. P. Di Santo, A. N. McKenzie, Science 348, aaa6566 (2015).
8. K. Moro et al., Nature 463, 540-544 (2010).
9. D. R. Neill et al., Nature 464, 1367-1370 (2010).
10. A. E. Price et al., Proc. Natl. Acad. Sci. U.S.A. 107,11489-1149 (2010).
11. H. Morita, K. Moro, S. Koyasu, J. Allergy Clin. Immunol. 138, 1253-1264 (2016).
12. D. L. Felten, S. Y. Felten, S. L. Carlson, J. A. Olschowka, S. Livnat, J. Immunol. 135 (suppl.), 755s-765s (1985).
13. S Livnat, S Y Felten, S L Carlson, D L Bellinger, D L Felten, J. Neuroimmunol. 10, 5-30 (1985).
14. J. B. Furness, Nat. Rev. Gastroenterol. Hepatol. 9, 286-294 (2012).
15. E. M. Sternberg, Nat. Rev. Immunol. 6, 318-328 (2006).
16. J. C. Nussbaum et al., Nature 502, 245-248 (2013).
17. S. Talbot et al., Neuron 87, 341-354 (2015).
18. L. Galle-Treger et al., Nat. Commun. 7, 13202 (2016).
19. I. J. Elenkov, R. L. Wilder, G. P. Chrousos, E. S. Vizi, Pharmacol. Rev. 52, 595-638 (2000).
20. V. Cardoso et al., Nature 549, 277-281 (2017).
21. C. S. N. Klose et al., Nature 549, 282-286 (2017).
22. A. Wallrapp et al., Nature 549, 351-356 (2017).
23. S. Ibiza et al., Nature 535, 440-443 (2016).
24. E. C. Mackley et al., Nat. Commun. 6, 5862 (2015).
25. T. Hoyler et al., Immunity 37, 634-648 (2012).
26. S. H. Wong et al., Nat. Immunol. 13, 229-236 (2012).
27. C. J. Oliphant et al., Immunity 41, 283-295 (2014).
28. P. Panina-Bordignon et al., J. Clin. Invest. 100, 1513-1519 (1997).